Atlas Trials

Treatment of Central Retinal Vein Occlusion Using Stem Cells Study

Clinical trial NCT03981549 · COMPLETED

Trial details

NCT number
NCT03981549
Sponsor
The Emmes Company, LLC
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Central Retinal Vein Occlusion
Start date
2019-10-22
Primary completion
2023-11-07
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.